This profile was last updated on .
Is this you? Claim your profile.
American Biosources Inc
American Biosources (ABS) Inc. is a Biopharmaceutical & Biotechnology R & D, Process Development, and Clinical stage company with few products in pipeline within the following Strategic Business Units:
• Novel Vaccines (Viral, Bacterial).
• Innovative B...
Find other employees at this company (1)
(14 Total References)
India | EEFC Energy
Dr. Niranjan Kumar
Chairman / CEO
AMERICAN BIOSOURCES INC.
80 Main Street, 5th Floor, West Orange, NJ 07052, USA
Dr. Niranjan Kumar, Chairman/CEO ABS Novacell LLC has partnered with EEFC to accomplish renewable energy projects in India in association with Suryachakra Power Corporation.
Our current project - producing pellets from biomass to be used as fuel.
Global Bio Pharma Conference Group welcomes you...
Dr. Niranjan Kumar , Ph. D, EMTM (U PENN)
CEO, American Biosources, Inc, USA
& Chairman & CEO, ABS Novacell Pvt. Ltd.
Leadership « Varhad Capital
Dr. Niranjan Kumar, Ph.D. Executive Masters in Technology Management
Dr. Kumar is a member of board of advisors of The Varhad Group.
Dr. Kumar is currently Chairman and CEO of ABS Novacell Ltd.
He has a PhD in Biochemistry & Microbiology, Executive Masters in Technology Management (Pen Eng & Wharton Business School, UPenn) and has 25 years of extensive experience in Biologics (novel vaccines) & Biotherapeutics (Proteins & Monoclonal Antibodies) & Blood Plasma Products.
He has founded 2 companies in the US (American Bio Sources Inc.
Innovative Biopharmaceutical Products company & ABSINCGROUP - Strategic Management Consulting & Services) and one non-profit Organization in the US (Global Bio Pharma Conference Group).
Dr Kumar has held numerous senior management positions such as Senior VP, Wockhardt Biotech Strategic Business Unit, Executive Director, Novavax Inc.
Director in Sanofi-Aventis, Group Leader Wyeth (Pfizer, USA) and Merck & Co.
Inc. USA and managed multi-billion dollars budgets, projects, P &L and people and various sites in the World.
Prior to that Dr. Kumar was Asst.
Professor of Medicine, Pulmonary Critical Care/Lung Biology, State University of New York, Buffalo, NY and Post Doctoral Fellow in SUNY @ Buffalo and University of Rochester Medical School, Rochester, NY.
Dr. Kumar has contributed numerous block buster drugs launch and published numerous peer reviewed papers and presented in numerous International Conferences.
Dr.Kumar brought US $ 200M LOI from EXIM bank for renewable energy projects.
Dr. Niranjan Kumar ...
Dr. Niranjan Kumar Ph.D.
Dr. Kumar is in Biochemistry & Microbiology, Executive Masters in Technology Management (Penn Eng.
Dr. Kumar is Chairman & CEO of ABSNOVACELL LTD. and elected USP Expert committee (2005-2010) . Dr. Kumar is actively involved in business development & fund raising and held numerous senior management positions as Senior VP, Wockhardt Biotech Strategic Business Unit, responsible for managing the entire Biotechnology Manufacturing Operations for commercial products derived from core platform technologies (Yeast, E. coli, Mammalian cells) for Human r-DNA derived Insulin, Epo, and Insulin Glargine.
Dr. Kumar was an Executive Director, Novavax Inc.
USA, Technical (Analytical development, Product development) and Quality Operations, responsible for corporate strategies and functional leadership.
Prior to that Dr. Kumar worked as Dy.
Director in Sanofi-Aventis and responsible for 10 licensed products methods, process development, validation & CMC.
brings strong strategic corporate management, project, product, portfolio, business and communication and prioritization skills.
published over 51 peer-reviewed manuscripts and abstracts, presented 100 international and national lectures.
Dr. Kumar is member of numerous professional Organizations and has patents on novel technology.
Niranjan M. ...
Niranjan M. Kumar
Niranjan M. Kumar, President, ABS Inc.